Analysis of Revenues
Paying user area
Try for free
UnitedHealth Group Inc. pages available for free this week:
- Cash Flow Statement
- Analysis of Profitability Ratios
- Analysis of Liquidity Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Common Stock Valuation Ratios
- Capital Asset Pricing Model (CAPM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Net Profit Margin since 2005
- Operating Profit Margin since 2005
- Total Asset Turnover since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to UnitedHealth Group Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Revenues as Reported
UnitedHealth Group Inc., income statement, revenues
US$ in millions
| 12 months ended: | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UnitedHealthcare | |||||||||||
| Optum Health | |||||||||||
| Optum Insight | |||||||||||
| Optum Rx | |||||||||||
| Optum | |||||||||||
| Revenues, unaffiliated customers |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The revenue data reflects a clear upward trajectory across multiple business segments over the five-year period. There is consistent growth observed in both the UnitedHealthcare and Optum divisions, contributing to an overall increase in revenues from unaffiliated customers.
- UnitedHealthcare Segment
- This segment shows steady growth each year, increasing from $200.1 billion in 2020 to nearly $296 billion in 2024. The growth appears robust, with more significant increments occurring in the later years, especially between 2022 and 2023 where revenue rose by over $30 billion.
- Optum Segment
- Composed of Optum Health, Optum Insight, and Optum Rx, this segment also demonstrates strong revenue growth. The total Optum revenue increased from approximately $55.5 billion in 2020 to around $99.3 billion in 2024, nearly doubling over the period.
- Optum Health
- Optum Health revenues exhibited significant growth from $16.6 billion in 2020 to $39.2 billion in 2024. This reflects an expansion more than doubling the segment's revenue within five years, signaling strong market demand or successful business strategies in health services.
- Optum Insight
- Revenue growth in Optum Insight shows more variability. Starting at $3.8 billion in 2020, it peaked at $7.9 billion in 2023 but then declined to $6.6 billion in 2024. Despite the dip in the final year, the overall trend remains positive with more than a 70% increase over the period.
- Optum Rx
- Optum Rx shows consistent revenue increases from $35 billion in 2020 to $53.4 billion in 2024. The growth pace accelerates notably in the final years, with a substantial jump from 2023 to 2024, indicating expanding pharmacy care services or volume increases.
- Revenues from Unaffiliated Customers
- Total revenues from unaffiliated customers improve markedly from $255.6 billion in 2020 to $395.1 billion in 2024. The continuous increase underscores overall strong business growth and customer base expansion outside existing affiliated entities, reflecting robust demand and market penetration.
In summary, the data indicates robust and sustained revenue expansion across the majority of the company’s segments, with particular strength in UnitedHealthcare and Optum Health. The slight fluctuation within Optum Insight suggests possible market or operational challenges mitigating against more consistent growth. Overall, the firm exhibits strong revenue growth trends, particularly in its diversified healthcare services and pharmacy operations.